FxPro Expands Investment Instruments With Medline Shares

FxPro has expanded its range of investment instruments by adding Medline shares to its trading offering, giving clients access to one of the most talked-about public listings of the year.

Medline made a strong debut on the Nasdaq, with shares jumping 41% on their first day of trading. The listing marks the largest initial public offering of 2025 so far and reflects renewed interest in established healthcare and industrial companies, even as global markets remain mixed.

The company officially entered public markets after raising billions of dollars in a high-profile IPO that attracted strong participation from both institutional and retail investors. Heavy demand during early trading pushed the stock sharply higher, setting the tone for active price movement as the market begins to assess Medline’s valuation and long-term prospects.

FxPro Expands Investment Instruments With Medline Shares

Founded more than five decades ago, Medline is among the world’s largest suppliers of medical and surgical products. The company serves hospitals, clinics, and healthcare providers across multiple regions, offering a wide catalogue that spans everyday medical consumables as well as specialized equipment used in clinical settings. Its scale, long operating history, and established relationships within the healthcare sector have positioned it as a familiar name for many investors.

With Medline shares now available on FxPro, traders can gain exposure to the stock as it navigates its early days as a publicly traded company. Post-IPO periods often bring heightened price movement as liquidity builds and market participants react to earnings expectations, analyst coverage, and broader sector trends.

FxPro clients can trade Medline with flexible conditions, including the ability to start from as little as 0.01 shares. The broker allows traders to take both long and short positions, depending on their market outlook, and to access the stock through the MT5 platform or the FxPro App. Trades are supported by fast execution and competitive spreads, aligning with FxPro’s broader approach to multi-asset trading.

The addition of Medline reinforces FxPro’s focus on expanding access to newly listed stocks, including major IPOs, as they enter public markets.

Also, stay updated with the Latest Broker News. Happy Trading!